Impact of Organ-at-Risk (OAR) Radiation Dosimetry on Acute and Late Toxicity after Prostate Stereotactic Body Radiation Therapy (SBRT): A Post-Hoc Analysis of a Phase III Randomized Clinical Trial of MRI-Guided vs. CT-Guided SBRT
Beth K. Neilsen(University of California, Los Angeles), Amar U. Kishan(University of California, Los Angeles), J.P. Neylon(University of California, Los Angeles), M. Cao(University of California, Los Angeles), Dan Ruan(University of California, Los Angeles), Natalie Chong(University of California, Los Angeles), Leonardo Guedes Moreira Valle(University of California, Los Angeles), T.M. Ma(University of California, Los Angeles), V. Basehart(University of California, Los Angeles), M.L. Steinberg, Yingli Yang(University of California, Los Angeles), Daniel Low(Washington University in St. Louis), Lily Zello(University of California, Los Angeles), T. Jiang, James Lamb(University of California, Los Angeles), Maria Casado(University of California, Los Angeles), H. Wilhame(University of California, Los Angeles)
International Journal of Radiation Oncology*Biology*Physics
September 27, 2024
Cited by 0
Related Papers
Adaptive Radiation Therapy (ART) Strategies and Technical Considerations: A State of the ART Review From NRG Oncology
|International Journal of Radiation Oncology*Biology*Physics|2020|314
A Multi-Institutional Experience of MR-Guided Liver Stereotactic Body Radiation Therapy
|Advances in Radiation Oncology|2018|161
Longitudinal diffusion MRI for treatment response assessment: Preliminary experience using an MRI‐guided tri‐cobalt 60 radiotherapy system
|Medical Physics|2016|119
On a PCA-based lung motion model
|Physics in Medicine and Biology|2011|109